How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

804 results for

Priapism

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

641. penile diseases and conditions

penile diseases and conditions penile diseases and conditions - General Practice Notebook This site is intended for healthcare professionals General Practice Notebook | Medical search penile diseases and conditions The most common penile disorders are those involving the foreskin: balanitis phimosis paraphimosis balanitis xerotica obliterans Rarer penile disorders include: priapism penile carcinoma Peyronie's disease Links: General Practice Notebook General Practice Notebook The information

2010 GP Notebook

642. Benign Prostatic Hyperplasia (BPH) Management in Primary Care

on the medication for some time, so patients who had dropped out early because of side effects would have been missed. Tadalafil, Vardenafil and sildenafil. All alpha blockers can cause hypotension and priapism, raising concern that alpha blockers might cause serious side effects when administered with drugs for erectile dysfunction. Erectile dysfunction drugs and prazosin, terazosin, or alfuzosin should be given at least 4 hours apart. In a small (22 patient) placebo-controlled study of starting vardenafil

2007 Veterans Affairs Evidence-based Synthesis Program Reports

643. Neck and back trauma

survey, remember that abdominal and chest signs may be unreliable in the presence of SCI. Assessment in the unconscious patient It is not possible to fully assess the integrity of the spinal cord in the unconscious patient. The following signs may help: ? diaphragmatic or abdominal breathing ? hypotension (BP often <80-90 mmHg) with bradycardia ? warm peripheries or vasodilatation in presence of low blood pressure ? ?accid (?oppy) muscles with absent re?exes ? priapism – partial or full erection

2006 Joint Royal Colleges Ambulance Liaison Committee

645. Trauma - neck and back trauma

survey, remember that abdominal and chest signs may be unreliable in the presence of SCI. Assessment in the unconscious patient It is not possible to fully assess the integrity of the spinal cord in the unconscious patient. The following signs may help: ? diaphragmatic or abdominal breathing ? hypotension (BP often <80-90 mmHg) with bradycardia ? warm peripheries or vasodilatation in presence of low blood pressure ? ?accid (?oppy) muscles with absent re?exes ? priapism – partial or full erection

2007 Joint Royal Colleges Ambulance Liaison Committee

646. Sildenafil: an oral drug for the treatment of male erectile dysfunction

effects: Adverse events reported in >2% (range 2% - 10%) of patient treated (2RCTs) include headache, flushing, dyspepsia, nasal congestion, urinary tract infection, abnormal vision, diarrhoea, dizziness, rash, respiratory tract infection. No cases of priapism were reported in any of the sildenafil studies. Cardiovascular: 18 RCTs give an overall incidence of cardiovascular events (other than flushing) of 3.0% with sildenafil and 3.5% with placebo. A comparable incidence rate was seen with sildenafil

1998 DARE.

647. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction

were assessed: return to intercourse; patient and partner satisfaction; drop-out; systemic adverse events including hypotension, tachycardia, vasovagal response, liver dysfunction, flushing and dizziness; local adverse events including petechiae, ecchymoses, haematomas, abrasions and discomfort on ejaculation; discomfort or pain; prolonged erection or priapism; fibrosis, nodules, or plaques; device problems including infection, mechanical failure and prosthesis erosion; and surgical complications (...) , 0.898); partner satisfaction, median 0.886 (95% CI: 0.619, 0.989); drop-outs, median 0.346 (95% CI: 0.098, 0.677); systemic adverse events, median 0.019 (95% CI: 0.008, 0.036); local adverse events, median 0.098 (95% CI: 0.057, 0.151); discomfort or pain, median 0.233 (95% CI: 0.175, 0.304); prolonged erection or priapism, median 0.031 (95% CI: 0.017, 0.053); fibrosis, nodules or plaques, median 0.001 (95% CI: 0.000, 0.008). Patients should be informed that a prolonged erection can occur

1996 DARE.

648. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. Full Text available with Trip Pro

precursor l-arginine. This diminished bioavailability of nitric oxide promotes a hemolysis-vascular dysfunction syndrome, which includes pulmonary hypertension, cutaneous leg ulceration, priapism, and ischemic stroke. Additional correlates of this vasculopathy include activation of endothelial cell adhesion molecules, platelets, and the vascular protectant hemeoxygenase-1. Some known risk factors for atherosclerosis are also associated with sickle cell vasculopathy, including low levels

2008 JAMA

649. Titan® One Touch Release Inflatable Penile Prosthesis

dexterity or mental ability to operate the pump Participant has chordee or priapism Participant has penile sensory neuropathy Participant has serious bleeding disorder Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00731939 Locations Layout table

2008 Clinical Trials

650. Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)

Participant has a compromised immune system Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment Participant does not have manual dexterity or mental ability to operate the pump Participant has an active urogenital infection or active skin infection in region of surgery Participant is diagnosed with fibrotic disease, such as priapism or Peyronie's disease Participant is diagnosed with Chordee Participant has neuropathy Participant has a serious

2008 Clinical Trials

651. Research Evaluating an Investigational Medication for Erectile Dysfunction

the study; Androgen replacement therapy that has not been stable for at least 3 month; Initiation or change in dose of any alpha-blocker within 14 days prior to randomization; ED as a result of spinal cord injury or radical prostatectomy; Untreated hypogonadism or low serum total testosterone History of or predisposition to priapism; Any penile implant; Elevated PSA, other evidence of prostate cancer, or previous radical prostatectomy; History of any malignancy (except basal cell carcinoma or squamous

2008 Clinical Trials

652. Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

by a glomerular filtration rate of 30% - 50% of the predicted normal Alloimmunization that is sufficient to interfere with the efficacy of chronic transfusion therapy Chronic or recurrent priapism Major visual impairment in one or both eyes with bilateral proliferative retinopathy Persistent disabling pain (≥ 2 episodes per year) despite trials of chronic transfusion and/or hydroxyurea at recommended doses for at least 6 months duration Additional General Criteria: Subjects must also meet all of the following

2008 Clinical Trials

653. Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

blood pressure [DBP] less than 50 mm Hg) Uncontrolled systemic hypertension (i.e., SBP greater than 180 mm Hg or DBP greater than 100 mm Hg) Known penile deformities or conditions (e.g., sickle cell anemia, multiple myeloma, leukemia) that may predispose participant to priapism Aspartate aminotransferase (AST), serum glutamic pyruvic transaminase (SGPT), alanine aminotransferase (ALT), or serum glutamic oxaloacetic transaminase (SGOT) greater than three times the upper limit of normal range Kidney

2007 Clinical Trials

654. Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis

retinopathy. Osteonecrosis of multiple bones Chronic debilitating pain secondary to vasoocclusive crisis (>= 3 episodes per year for >= 3 years) Recurrent priapism Allo-immunization with the development of antibodies following chronic transfusion therapy Patients with HOMOZYGOUS SICKLE CELL ANEMIA or SICKLE/BETA THALASSEMIA with the following criteria will be considered for accrual on this protocol Patients < 2 years with high WBC counts and/or >1 episode of dactylitis and/or a Hgb < 7 g/dl History

2007 Clinical Trials

655. Assessment of the Functional Significance of Accessory Pudendal Arteries

mellitus Patient who have received prior radiation therapy to the pelvis or prostate Patients requiring anticoagulation postoperatively Known allergy to Phenylephrine, Alprostadil, Papaverine or Phentolamine Patients whose systolic blood pressure is below 90 mmHg at the time of evaluation despite routine measures taken by the anesthesiologist at his best criteria. Patients with labile hypertension or history of prior priapism Patients with penile scarring or penile prosthesis Patients

2007 Clinical Trials

656. CSP #563

with PTSD will not be exclusionary (see below). Medications/Therapies: Current use of prazosin or other alpha-1 antagonist. Previous adequate trial of prazosin for PTSD. Subjects on trazodone will undergo a 2-week washout period before baseline assessment. (Combining prazosin and trazodone may increase risk of priapism). Sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) will be not be permitted during the study dose titration period because of increased risk of hypotension in combination

2007 Clinical Trials

657. Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

disease (electrophoretic HPLC documentation of SS, SC, Sb thalassemia or other major sickling phenotype such as SD, SO-Arab or SLepore is required). At least three weeks has elapsed since hospitalization for acute chest syndrome, pain crisis, infection or other complication of SCD. Absence of acute infection, pain crisis, or other acute complication of SCD. (Chronic SCD complications such as stuttering priapism, stable chronic pain and leg ulcers are not reasons for exclusion.) Inclusion criteria

2007 Clinical Trials

658. A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function

of moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic impairment In men: Clinically significant chronic haematological disease which may lead to priapism History of malignancy of any organ system within the past 5 years Bleeding disorder Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its

2007 Clinical Trials

659. Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin

or on assessment at the screening or baseline visits (defined as a decrease of 10 mm Hg or greater after standing for 2 minutes). Current antihypertensive treatment History of significant cardiac disease, including coronary artery disease Current use of phosphodiesterase type 5 inhibitors: sildenafil (ViagraTM), tadalafil (CialisTM), or vardenafil (LevitraTM) History of priapism (persistent and painful erection) Contacts and Locations Go to Information from the National Library of Medicine To learn more about

2007 Clinical Trials

660. A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia

P45 3A4 (eg. phenytoin, carbamezapine, Phenobarbital, rifampin) Unstable medical disease Significant cardiac disease Bleeding disorder Peptic ulcer disease Hepatic impairment Moderate or greater renal impairment History of migraines Currently taking nitrates or alpha blockers Resting blood pressure < 90/50 or >140/90 mm. History of intolerance to PDE5 inhibitors History of inappropriate sexual behavior (eg, masturbation in public, stalking, assault) History of priapism Pregnant or lactating

2007 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>